Centice Corporation Completes $6.1M Series C Financing

Centice Corporation completed a $6.1m Series C financing round led by existing investors Aurora Funds, S-Group Direct Investments, Innovation Ventures and several individuals as well as new investor Fulcrum Financial Group. 

The funds will be used to support ongoing commercialization efforts for release 3.0 of Centice’s PASS Rx prescription verification product for the retail and hospital outpatient pharmacy marketplace.

On this point, Scott Albert, CEO and Chairman of the Centice Board of Directors, was reported as saying: “These funds will allow us to appropriately position, market and sell the product to pharmacies nationwide”.

Founded in 2004, Centice, is headquartered in Morrisville, NC. Its flagship product, PASS Rx, improves the verification process for dispensed medications, thereby improving quality and optimizing workflow in the pharmacy.



Join the discussion